No Data
No Data
Armata Pharmaceuticals Price Target Maintained With a $7.00/Share by HC Wainwright & Co.
Armata Pharmaceuticals Price Target Maintained With a $7.00/Share by HC Wainwright & Co.
HC Wainwright & Co. Reiterates Buy on Armata Pharmaceuticals, Maintains $7 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates Armata Pharmaceuticals with a Buy and maintains $7 price target.
Analysts Offer Insights on Healthcare Companies: Valneva (VALN), Denali Therapeutics (DNLI) and Armata Pharmaceuticals (ARMP)
Armata Pharmaceuticals Q1 2024 Earnings: Narrower Losses and Strategic Advances
Armata Pharmaceuticals Q1 EPS $(0.69) Misses $(0.31) Estimate, Sales $966.00K Miss $1.10M Estimate
Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.31) by 122.58 percent. This is a 72.5 percent decrease over losses
Armata Pharmaceuticals | 10-Q: Quarterly report